DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Specialty Active Pharmaceutical Ingredients (API) Market: Global Industry Analysis and Opportunity Assessment, 2016-2024" report to their offering.
The specialty active pharmaceutical ingredient market is expected to register a CAGR of 7.9%.
This study demonstrates market dynamics and trends in major countries that are expected to influence the current environment and future status of the global specialty active pharmaceutical ingredient market over the forecast period.
The global specialty active pharmaceutical ingredients market report provides analysis and insights on active pharmaceutical ingredients, which are biologically active chemicals used as intermediate components in pharmaceutical manufacturing such as tablets, capsules, syrups, etc.
To understand and assess various opportunities in this market, the report is categorically split into three sections, namely market analysis by product type, consumption and region. The report analyzes the global specialty active pharmaceutical ingredient market in terms of value (US$ Mn).
The report starts with an overview of the global specialty active pharmaceutical ingredient market. In the same section, the author covers the global specialty active pharmaceutical ingredient market performance in terms of value. This section also includes analysis of key trends, drivers, and restraints from supply and demand perspectives. The report also covers the opportunities in the global specialty active pharmaceutical ingredient market.
The next section of the report analyzes the market on the basis of product type and presents the forecast in terms of value for all years till 2024.
On the basis of product type, the market has been segmented as follows:
- Steroidal API
- Peptide API
- Carbohydrate API
- Small Molecule API
- High Potency API
Consumption segments covered in the report are as follows:
- In-house
- Outsourced
Key Topics Covered:
1. Preface
2. Executive Summary
3. Market Definition
4. Oligonucleotide Drug Pipeline Analysis (miRNA, siRNA and RNAi Drugs)
5. Global Therapeutic Drugs Market, by Type of API, 2014-2024 (US$ Mn)
6. Global Specialty Active Pharmaceutical Ingredients Market Revenue, by Consumption, 2014-2024
7. Global Specialty Active Pharmaceutical Ingredients Sub-Segment Market Revenue, by Product Type, 2014-2024
8. North America API Market Revenue, 2014-2024 (US$ Mn)
9. Company Profiles
- Almac
- AmbioPharm Inc.
- Ash Stevens Fermion (public) Olon S.p.A.
- Avecia OligoMedicines
- BCN Peptides
- BioSpring
- Cepia Sanofi
- Corden Pharma
- Dalton Pharma Services
- Dextra Laboratories Limited
- Dolder AG
- FarmaBios S.p.A.
- Gadea Grupo Farmacéutico
- GlycoSyn
- Inalco Pharma
- Johnson Matthey
- Noramco Inc.
- Pepscan
- Pfanstiehl Inc.
- Pfizer CenterSource
- PolyPeptide Laboratories
- Provence Technologies Groups
- ST Pharm Oligo Center
- Steroid S.p.A.
- Santaris Pharma
- SennChemicals AG
- Siegfried
- Sussex Research
- Symbiotec Pharma Lab Pvt. Ltd.
For more information about this report visit http://www.researchandmarkets.com/research/r7vpgz/specialty_active.
Related Topics: Pharmaceuticals
